JP Morgan Chase’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
JP Morgan Chase's ALT Position: Q3 2026 in Review
JP Morgan Chase increased its Altimmune (ALT) stake by 6.7% in Q3 2026, buying an estimated $22K and bringing the position to 113,791 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #5447.
JP Morgan Chase first reported a position in ALT in Q4 2016 and has held it in 29 quarters since. The position peaked at $8.31M in Q3 2022. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- JP Morgan Chase held 113,791 shares of Altimmune worth $338K as of Q3 2026.
- JP Morgan Chase bought 7,166 Altimmune shares in Q3 2026, an estimated $22K.
- Altimmune made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5447 holding.
- JP Morgan Chase first reported a position in Altimmune in Q4 2016 and has held it in 29 quarters since.
- JP Morgan Chase's Altimmune position peaked at $8.31M in Q3 2022.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.